Last update 05 Apr 2024

SI-F019

Overview

Basic Info

Drug Type
Fusion protein
Synonyms
Recombinant human ACE2 fusion protein - Sichuan Baili Pharmaceutical, F019, SI F019
+ [2]
Mechanism
Ang II antagonists(Angiotensin II antagonists), SARS-CoV-2 S protein inhibitors(Coronavirus spike glycoprotein inhibitors)
Inactive Indication-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-

R&D Status

IndicationHighest PhaseCountry/LocationOrganization
COVID-19Phase 2CN
More
Pulmonary Arterial HypertensionPhase 2CN
More
Respiratory Distress SyndromePhase 2CN
More
Login to view more data

Clinical Trial Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
-
gveiwppdtd(icodzxwqhm) = ouvfjwfwcn jchoccaase (rraabiaxby, 19 - 496)
-
20 May 2010
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial Analysis

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free